Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
作者信息
Curtis J E
出版信息
Cancer Chemother Rep. 1974 Nov-Dec;58(6):883-8.
PMID:4614897
Abstract
摘要
相似文献
1
Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
Cancer Chemother Rep. 1974 Nov-Dec;58(6):883-8.
2
Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
Cancer Treat Rep. 1982 Jan;66(1):199-200.
3
4
Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
Cancer Chemother Rep 3. 1973 Mar;4(2):125-32.
5
5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study.5-氟尿嘧啶（NSC-19893）与环磷酰胺（NSC-26271）治疗支气管癌的临床研究比较：临床研究结果
Cancer Chemother Rep. 1975 Sep-Oct;59(5):1025-6.
6
Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma.
Cancer. 1980 Jan 1;45(1):6-10. doi: 10.1002/1097-0142(19800101)45:1<6::aid-cncr2820450103>3.0.co;2-y.
7
Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma.
Cancer Lett. 1975 Nov;1(2):97-102. doi: 10.1016/s0304-3835(75)95630-x.
8
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Schweiz Med Wochenschr. 1977 Jul 2;107(26):912-5.
9
10
Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation.
Cancer Chemother Rep. 1974 Nov-Dec;58(6):919-26.
Zotero 插件